Loading…

Subjective effect of magnetic resonance-guided focused ultrasound surgery for uterine fibroids

Aim:  We treated 69 patients with symptomatic uterine fibroids using a magnetic resonance‐guided focused ultrasound surgery (MRgFUS) system. Our objective was to determine the clinical outcome of MRgFUS, focusing on symptom improvement, with emphasis on the time and extent of improvement. Methods: ...

Full description

Saved in:
Bibliographic Details
Published in:The journal of obstetrics and gynaecology research 2007-12, Vol.33 (6), p.834-839
Main Authors: Funaki, Kaoru, Sawada, Katsuhiro, Maeda, Fumio, Nagai, Syuji
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5545-2160e95bb98ee1d72a7b8d38cb46d520f1eb89c6cbce350c19a2b368a79f7f3a3
cites cdi_FETCH-LOGICAL-c5545-2160e95bb98ee1d72a7b8d38cb46d520f1eb89c6cbce350c19a2b368a79f7f3a3
container_end_page 839
container_issue 6
container_start_page 834
container_title The journal of obstetrics and gynaecology research
container_volume 33
creator Funaki, Kaoru
Sawada, Katsuhiro
Maeda, Fumio
Nagai, Syuji
description Aim:  We treated 69 patients with symptomatic uterine fibroids using a magnetic resonance‐guided focused ultrasound surgery (MRgFUS) system. Our objective was to determine the clinical outcome of MRgFUS, focusing on symptom improvement, with emphasis on the time and extent of improvement. Methods:  Patients who would have been otherwise offered conventional surgery were considered for eligibility. They were asked to report their symptom severities before and after treatment on the same query form. The questionnaire, given 6 months after treatment, included a question asking when the patients' symptoms started to improve. Their fibroids were classified into three types according to the signal intensity on T2‐weighted magnetic resonance images: type 1, low intensity as skeletal muscle, type 2, intermediate intensity, lower than myometrium but higher than skeletal muscle; and type 3, high intensity, the same as or higher than myometrium. Results:  No severe adverse events occurred in any of the patients. Seven patients required alternative treatment after MRgFUS, with five of them having type 3 fibroids. Mean symptom scores were all reduced after MRgFUS, regardless of the symptom types. Frequent urination improved first, while heavy bleeding took longer to resolve than the other symptoms. Conclusion:  MRgFUS is an effective and safe method for treating symptomatic uterine fibroids, especially for type 1 and type 2 fibroids. Type 3 fibroids, however, are difficult to treat using the current MRgFUS system.
doi_str_mv 10.1111/j.1447-0756.2007.00665.x
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68512562</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20101866</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5545-2160e95bb98ee1d72a7b8d38cb46d520f1eb89c6cbce350c19a2b368a79f7f3a3</originalsourceid><addsrcrecordid>eNqNkc1u1DAUhS0EoqXwCsgrdgl2HP9EYoMqSEEjKrVF7LBs53rkIZMUO4aZt6-HGZUleHOPdL9zLZ2DEKakpuW93dS0bWVFJBd1Q4isCRGC17sn6Pxx8bRo1tJKESnO0IuUNoRQ2VH1HJ1RVXTL6Tn6fpvtBtwSfgEG74vCs8dbs55gCQ5HSPNkJgfVOocBBuxnl1OZeVyiSXOeBpxyXEPcl1XEeYEYJsA-2DiHIb1Ez7wZE7w6zQv09eOHu8uranXdf7p8v6oc5y2vGioIdNzaTgHQQTZGWjUw5WwrBt4QT8GqzglnHTBOHO1MY5lQRnZeembYBXpzvHsf558Z0qK3ITkYRzPBnJMWitOGi-afYEMooUqIAqoj6OKcUgSv72PYmrjXlOhDCXqjD1nrQ9b6UIL-U4LeFevr0x_ZbmH4azylXoB3R-B3GGH_34f15-u-iGKvjvaQFtg92k38oYVkkutvX3otWNd3q5teX7EHKx6mAQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20101866</pqid></control><display><type>article</type><title>Subjective effect of magnetic resonance-guided focused ultrasound surgery for uterine fibroids</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Funaki, Kaoru ; Sawada, Katsuhiro ; Maeda, Fumio ; Nagai, Syuji</creator><creatorcontrib>Funaki, Kaoru ; Sawada, Katsuhiro ; Maeda, Fumio ; Nagai, Syuji</creatorcontrib><description>Aim:  We treated 69 patients with symptomatic uterine fibroids using a magnetic resonance‐guided focused ultrasound surgery (MRgFUS) system. Our objective was to determine the clinical outcome of MRgFUS, focusing on symptom improvement, with emphasis on the time and extent of improvement. Methods:  Patients who would have been otherwise offered conventional surgery were considered for eligibility. They were asked to report their symptom severities before and after treatment on the same query form. The questionnaire, given 6 months after treatment, included a question asking when the patients' symptoms started to improve. Their fibroids were classified into three types according to the signal intensity on T2‐weighted magnetic resonance images: type 1, low intensity as skeletal muscle, type 2, intermediate intensity, lower than myometrium but higher than skeletal muscle; and type 3, high intensity, the same as or higher than myometrium. Results:  No severe adverse events occurred in any of the patients. Seven patients required alternative treatment after MRgFUS, with five of them having type 3 fibroids. Mean symptom scores were all reduced after MRgFUS, regardless of the symptom types. Frequent urination improved first, while heavy bleeding took longer to resolve than the other symptoms. Conclusion:  MRgFUS is an effective and safe method for treating symptomatic uterine fibroids, especially for type 1 and type 2 fibroids. Type 3 fibroids, however, are difficult to treat using the current MRgFUS system.</description><identifier>ISSN: 1341-8076</identifier><identifier>EISSN: 1447-0756</identifier><identifier>DOI: 10.1111/j.1447-0756.2007.00665.x</identifier><identifier>PMID: 18001451</identifier><language>eng</language><publisher>Melbourne, Australia: Blackwell Publishing Asia</publisher><subject>Female ; focused ultrasound ; Humans ; Leiomyoma - diagnosis ; Leiomyoma - diagnostic imaging ; Leiomyoma - surgery ; Magnetic Resonance Imaging ; Prospective Studies ; Surveys and Questionnaires ; symptom relief ; Treatment Outcome ; Ultrasonography ; uterine fibroid ; Uterine Neoplasms - diagnosis ; Uterine Neoplasms - diagnostic imaging ; Uterine Neoplasms - surgery</subject><ispartof>The journal of obstetrics and gynaecology research, 2007-12, Vol.33 (6), p.834-839</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5545-2160e95bb98ee1d72a7b8d38cb46d520f1eb89c6cbce350c19a2b368a79f7f3a3</citedby><cites>FETCH-LOGICAL-c5545-2160e95bb98ee1d72a7b8d38cb46d520f1eb89c6cbce350c19a2b368a79f7f3a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/18001451$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Funaki, Kaoru</creatorcontrib><creatorcontrib>Sawada, Katsuhiro</creatorcontrib><creatorcontrib>Maeda, Fumio</creatorcontrib><creatorcontrib>Nagai, Syuji</creatorcontrib><title>Subjective effect of magnetic resonance-guided focused ultrasound surgery for uterine fibroids</title><title>The journal of obstetrics and gynaecology research</title><addtitle>J Obstet Gynaecol Res</addtitle><description>Aim:  We treated 69 patients with symptomatic uterine fibroids using a magnetic resonance‐guided focused ultrasound surgery (MRgFUS) system. Our objective was to determine the clinical outcome of MRgFUS, focusing on symptom improvement, with emphasis on the time and extent of improvement. Methods:  Patients who would have been otherwise offered conventional surgery were considered for eligibility. They were asked to report their symptom severities before and after treatment on the same query form. The questionnaire, given 6 months after treatment, included a question asking when the patients' symptoms started to improve. Their fibroids were classified into three types according to the signal intensity on T2‐weighted magnetic resonance images: type 1, low intensity as skeletal muscle, type 2, intermediate intensity, lower than myometrium but higher than skeletal muscle; and type 3, high intensity, the same as or higher than myometrium. Results:  No severe adverse events occurred in any of the patients. Seven patients required alternative treatment after MRgFUS, with five of them having type 3 fibroids. Mean symptom scores were all reduced after MRgFUS, regardless of the symptom types. Frequent urination improved first, while heavy bleeding took longer to resolve than the other symptoms. Conclusion:  MRgFUS is an effective and safe method for treating symptomatic uterine fibroids, especially for type 1 and type 2 fibroids. Type 3 fibroids, however, are difficult to treat using the current MRgFUS system.</description><subject>Female</subject><subject>focused ultrasound</subject><subject>Humans</subject><subject>Leiomyoma - diagnosis</subject><subject>Leiomyoma - diagnostic imaging</subject><subject>Leiomyoma - surgery</subject><subject>Magnetic Resonance Imaging</subject><subject>Prospective Studies</subject><subject>Surveys and Questionnaires</subject><subject>symptom relief</subject><subject>Treatment Outcome</subject><subject>Ultrasonography</subject><subject>uterine fibroid</subject><subject>Uterine Neoplasms - diagnosis</subject><subject>Uterine Neoplasms - diagnostic imaging</subject><subject>Uterine Neoplasms - surgery</subject><issn>1341-8076</issn><issn>1447-0756</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqNkc1u1DAUhS0EoqXwCsgrdgl2HP9EYoMqSEEjKrVF7LBs53rkIZMUO4aZt6-HGZUleHOPdL9zLZ2DEKakpuW93dS0bWVFJBd1Q4isCRGC17sn6Pxx8bRo1tJKESnO0IuUNoRQ2VH1HJ1RVXTL6Tn6fpvtBtwSfgEG74vCs8dbs55gCQ5HSPNkJgfVOocBBuxnl1OZeVyiSXOeBpxyXEPcl1XEeYEYJsA-2DiHIb1Ez7wZE7w6zQv09eOHu8uranXdf7p8v6oc5y2vGioIdNzaTgHQQTZGWjUw5WwrBt4QT8GqzglnHTBOHO1MY5lQRnZeembYBXpzvHsf558Z0qK3ITkYRzPBnJMWitOGi-afYEMooUqIAqoj6OKcUgSv72PYmrjXlOhDCXqjD1nrQ9b6UIL-U4LeFevr0x_ZbmH4azylXoB3R-B3GGH_34f15-u-iGKvjvaQFtg92k38oYVkkutvX3otWNd3q5teX7EHKx6mAQ</recordid><startdate>200712</startdate><enddate>200712</enddate><creator>Funaki, Kaoru</creator><creator>Sawada, Katsuhiro</creator><creator>Maeda, Fumio</creator><creator>Nagai, Syuji</creator><general>Blackwell Publishing Asia</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>200712</creationdate><title>Subjective effect of magnetic resonance-guided focused ultrasound surgery for uterine fibroids</title><author>Funaki, Kaoru ; Sawada, Katsuhiro ; Maeda, Fumio ; Nagai, Syuji</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5545-2160e95bb98ee1d72a7b8d38cb46d520f1eb89c6cbce350c19a2b368a79f7f3a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Female</topic><topic>focused ultrasound</topic><topic>Humans</topic><topic>Leiomyoma - diagnosis</topic><topic>Leiomyoma - diagnostic imaging</topic><topic>Leiomyoma - surgery</topic><topic>Magnetic Resonance Imaging</topic><topic>Prospective Studies</topic><topic>Surveys and Questionnaires</topic><topic>symptom relief</topic><topic>Treatment Outcome</topic><topic>Ultrasonography</topic><topic>uterine fibroid</topic><topic>Uterine Neoplasms - diagnosis</topic><topic>Uterine Neoplasms - diagnostic imaging</topic><topic>Uterine Neoplasms - surgery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Funaki, Kaoru</creatorcontrib><creatorcontrib>Sawada, Katsuhiro</creatorcontrib><creatorcontrib>Maeda, Fumio</creatorcontrib><creatorcontrib>Nagai, Syuji</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The journal of obstetrics and gynaecology research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Funaki, Kaoru</au><au>Sawada, Katsuhiro</au><au>Maeda, Fumio</au><au>Nagai, Syuji</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Subjective effect of magnetic resonance-guided focused ultrasound surgery for uterine fibroids</atitle><jtitle>The journal of obstetrics and gynaecology research</jtitle><addtitle>J Obstet Gynaecol Res</addtitle><date>2007-12</date><risdate>2007</risdate><volume>33</volume><issue>6</issue><spage>834</spage><epage>839</epage><pages>834-839</pages><issn>1341-8076</issn><eissn>1447-0756</eissn><abstract>Aim:  We treated 69 patients with symptomatic uterine fibroids using a magnetic resonance‐guided focused ultrasound surgery (MRgFUS) system. Our objective was to determine the clinical outcome of MRgFUS, focusing on symptom improvement, with emphasis on the time and extent of improvement. Methods:  Patients who would have been otherwise offered conventional surgery were considered for eligibility. They were asked to report their symptom severities before and after treatment on the same query form. The questionnaire, given 6 months after treatment, included a question asking when the patients' symptoms started to improve. Their fibroids were classified into three types according to the signal intensity on T2‐weighted magnetic resonance images: type 1, low intensity as skeletal muscle, type 2, intermediate intensity, lower than myometrium but higher than skeletal muscle; and type 3, high intensity, the same as or higher than myometrium. Results:  No severe adverse events occurred in any of the patients. Seven patients required alternative treatment after MRgFUS, with five of them having type 3 fibroids. Mean symptom scores were all reduced after MRgFUS, regardless of the symptom types. Frequent urination improved first, while heavy bleeding took longer to resolve than the other symptoms. Conclusion:  MRgFUS is an effective and safe method for treating symptomatic uterine fibroids, especially for type 1 and type 2 fibroids. Type 3 fibroids, however, are difficult to treat using the current MRgFUS system.</abstract><cop>Melbourne, Australia</cop><pub>Blackwell Publishing Asia</pub><pmid>18001451</pmid><doi>10.1111/j.1447-0756.2007.00665.x</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1341-8076
ispartof The journal of obstetrics and gynaecology research, 2007-12, Vol.33 (6), p.834-839
issn 1341-8076
1447-0756
language eng
recordid cdi_proquest_miscellaneous_68512562
source Wiley-Blackwell Read & Publish Collection
subjects Female
focused ultrasound
Humans
Leiomyoma - diagnosis
Leiomyoma - diagnostic imaging
Leiomyoma - surgery
Magnetic Resonance Imaging
Prospective Studies
Surveys and Questionnaires
symptom relief
Treatment Outcome
Ultrasonography
uterine fibroid
Uterine Neoplasms - diagnosis
Uterine Neoplasms - diagnostic imaging
Uterine Neoplasms - surgery
title Subjective effect of magnetic resonance-guided focused ultrasound surgery for uterine fibroids
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T20%3A10%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Subjective%20effect%20of%20magnetic%20resonance-guided%20focused%20ultrasound%20surgery%20for%20uterine%20fibroids&rft.jtitle=The%20journal%20of%20obstetrics%20and%20gynaecology%20research&rft.au=Funaki,%20Kaoru&rft.date=2007-12&rft.volume=33&rft.issue=6&rft.spage=834&rft.epage=839&rft.pages=834-839&rft.issn=1341-8076&rft.eissn=1447-0756&rft_id=info:doi/10.1111/j.1447-0756.2007.00665.x&rft_dat=%3Cproquest_cross%3E20101866%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5545-2160e95bb98ee1d72a7b8d38cb46d520f1eb89c6cbce350c19a2b368a79f7f3a3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=20101866&rft_id=info:pmid/18001451&rfr_iscdi=true